Chabiotech Co.,Ltd. (085660.KQ)
KRW 15280.0
(-2.98%)
KRW 15280.0
(-2.98%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -8.43 Billion KRW | 82.27% |
| 2022 | -47.54 Billion KRW | -240.36% |
| 2021 | -13.96 Billion KRW | 25.13% |
| 2020 | -18.65 Billion KRW | -140.23% |
| 2019 | 46.37 Billion KRW | 90.14% |
| 2018 | 24.38 Billion KRW | 152.45% |
| 2017 | -46.5 Billion KRW | -375.49% |
| 2016 | 16.87 Billion KRW | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 2.73 Billion KRW | 118.71% |
| 2024 Q1 | -14.59 Billion KRW | 12.76% |
| 2023 FY | -8.43 Billion KRW | 82.27% |
| 2023 Q2 | -2.7 Billion KRW | -155.32% |
| 2023 Q3 | 5.32 Billion KRW | 296.98% |
| 2023 Q4 | -16.73 Billion KRW | -414.35% |
| 2023 Q1 | 4.88 Billion KRW | 112.16% |
| 2022 Q2 | 314.28 Million KRW | 105.59% |
| 2022 FY | -47.54 Billion KRW | -240.36% |
| 2022 Q4 | -40.17 Billion KRW | -1838.43% |
| 2022 Q3 | -2.07 Billion KRW | -759.43% |
| 2022 Q1 | -5.62 Billion KRW | -329.64% |
| 2021 Q4 | 2.44 Billion KRW | -29.08% |
| 2021 FY | -13.96 Billion KRW | 25.13% |
| 2021 Q3 | 3.45 Billion KRW | 0.0% |
| 2020 FY | -18.65 Billion KRW | -140.23% |
| 2019 FY | 46.37 Billion KRW | 90.14% |
| 2018 FY | 24.38 Billion KRW | 152.45% |
| 2017 FY | -46.5 Billion KRW | -375.49% |
| 2016 FY | 16.87 Billion KRW | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| HLB Co., Ltd. | -189.07 Billion KRW | 95.541% |
| iNtRON Biotechnology, Inc. | -9.69 Billion KRW | 13.039% |
| BINEX Co., Ltd. | 4.67 Billion KRW | 280.512% |
| Bioneer Corporation | -10.58 Billion KRW | 20.362% |
| Anterogen.Co.,Ltd. | -2.84 Billion KRW | -196.786% |
| MEDIPOST Co., Ltd. | 5.83 Billion KRW | 244.371% |
| CrystalGenomics, Inc. | -48.92 Billion KRW | 82.767% |
| Helixmith Co., Ltd | -64.08 Billion KRW | 86.844% |
| Medy-Tox Inc. | 9.75 Billion KRW | 186.429% |
| Peptron, Inc. | -15.92 Billion KRW | 47.046% |
| Amicogen, Inc. | -23.28 Billion KRW | 63.797% |
| Genexine, Inc. | -66.87 Billion KRW | 87.392% |
| HLB Therapeutics Co.,Ltd. | -2.3 Billion KRW | -266.232% |
| LegoChem Biosciences, Inc. | -73.7 Billion KRW | 88.561% |
| ALTEOGEN Inc. | -3.37 Billion KRW | -150.054% |
| PharmaResearch Co., Ltd. | 76.55 Billion KRW | 111.014% |
| SillaJen, Inc. | -20.36 Billion KRW | 58.608% |
| JETEMA, Co., Ltd. | 13.96 Billion KRW | 160.37% |
| OliX Pharmaceuticals,Inc | -19.1 Billion KRW | 55.861% |
| Genomictree Inc. | -8.75 Billion KRW | 3.709% |
| MedPacto, Inc. | -35.32 Billion KRW | 76.132% |
| D&D Pharmatech | 3.93 Billion KRW | 314.328% |
| EASY BIO,Inc. | 15.54 Billion KRW | 154.242% |
| GI Innovation, Inc. | -55.49 Billion KRW | 84.807% |